Agency: Drug Enforcement Administration

Years: 20002001200220032004200520062007200820092010201120122013

Pages: 12345>»

[FR Doc E8-31084] 1. Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 29, 2008, Norac Inc., 405 S. Motor Avenue, P.O. Box 577, Azusa, California 917023232, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Tetrahydrocannabinols (7370),

Published: 2008-12-31 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-31079] 2. Importer of Controlled Substances; Notice of Application

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a registration under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the

Published: 2008-12-31 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

[FR Doc E8-31080] 3. Importer of Controlled Substances; Notice of Application

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II and prior to issuing a registration under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk

Published: 2008-12-31 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-31081] 4. Importer of Controlled Substances; Notice of Registration

By Notice dated September 22, 2008, and published in the Federal Register on September 29, 2008, (73 FR 56611), GE Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 600041412, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Cocaine (9041), a basic class of controlled

Published: 2008-12-31 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-30800] 5. Combat Methamphetamine Epidemic Act of 2005: Fee for Self- Certification for

To comply with the requirement of the Controlled Substances Act that fees be set at a level to ensure the recovery of the full costs of operating the various aspects of the Diversion Control Program, this Final Rule establishes an annual selfcertification fee for certain ``regulated sellers,'' that is, persons and entities selling scheduled listed

Published: 2008-12-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-30808] 6. Assessment of Annual Needs for the List I Chemicals Ephedrine,

This notice establishes, on an interim basis, the Assessment of Annual Needs for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. DEA seeks comment regarding the Assessment of Annual Needs for those List I chemicals. The Assessment of Annual Needs for these chemicals will be proposed to be revised, pursuant to DEA

Published: 2008-12-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-30807] 7. Controlled Substances: Established Initial Aggregate Production Quotas for

This notice establishes initial 2009 aggregate production quotas for
[[Page 79515]]
controlled substances in schedules I and II of the Controlled Substances Act (CSA).

Published: 2008-12-29 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-30506] 8. Nirmal Saran, M.D.; Nisha Saran, D.O.; Affirmance of Suspension Orders

On September 19, 2005, I, the Deputy Administrator of the Drug Enforcement Administration, issued an Order to Show Cause and Immediate Suspension of Registration to both Nirmal Saran, M.D., and Nisha Saran, D.O. (Respondents), of Arlington, Texas. The Orders immediately suspended each Respondent's DEA Certificate of Registration as a

Published: 2008-12-23 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

[FR Doc E8-29407] 9. Your Druggist Pharmacy; Revocation of Registration

On May 28, 2008, I, the Deputy Administrator of the Drug Enforcement Administration, issued an Order to Show Cause and Immediate Suspension of Registration to Your Druggist Pharmacy (Respondent), of Coral Springs, Florida. The Order immediately suspended Respondent's DEA Certificate of Registration, AY1916103, which authorizes it to dispense

Published: 2008-12-12 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-29406] 10. Hicham K. Riba, D.D.S.; Revocation of Registration

On February 1, 2008, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, issued an Order to Show Cause to Hicham K. Riba, D.D.S. (Respondent), of Chicago, Illinois. The Show Cause Order proposed the revocation of Respondent's DEA Certificate of Registration, BR5325091, as a practitioner, on the

Published: 2008-12-12 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28970] 11. Importer of Controlled Substances; Notice of Registration

By Notice dated July 29, 2008, and published in the Federal Register on August 6, 2008, (73 FR 45779), Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28985] 12. Importer of Controlled Substances; Notice of Registration

By Notice dated March 19, 2008 and published in the Federal Register on March 28, 2008, (73 FR 16717), Mallinckrodt Inc., 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28987] 13. Importer of Controlled Substances; Notice of Registration

By notice dated February 20, 2008, and published in the Federal Register on February 29, 2008 (73 FR 11149), Supernus Pharmaceuticals, 1550 East Gude Drive, Rockville, Maryland 20850, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28999] 14. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated July 29, 2008, and published in the Federal Register on August 6, 2008, (73 FR 45785), American Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28994] 15. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated July 30, 2008, and published in the Federal Register on August 6, 2008, (73 FR 45785), Austin Pharma, LLC., 811 Paloma Drive, Suite A, Round Rock, Texas 786652402, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28993] 16. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated July 29, 2008, and published in the Federal Register on August 6, 2008, (73 FR 45784), Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28996] 17. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated July 28, 2008, and published in the Federal Register on August 6, 2008, (73 FR 45784), Chemic Laboratories, Inc., 480 Neponset Street, Building 7, Canton, Massachusetts 02021, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28992] 18. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated July 30, 2008, and published in the Federal Register on August 6, 2008, (73 FR 45785), Cody Laboratories, 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28989] 19. Manufacturer of Controlled Substances; Notice of Registration

By notice dated February 13, 2008, and published in the Federal Register on February 21, 2008, (73 FR 9592), Siemens Healthcare Diagnostics Inc., 100 GBC Drive, Mail Stop 514, Newark, Delaware 19702, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of

Published: 2008-12-08 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28756] 20. Importer of Controlled Substances; Notice of Application

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk

Published: 2008-12-05 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28748] 21. Importer of Controlled Substances; Notice of Application

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a registration under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the

Published: 2008-12-05 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28853] 22. Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 18, 2008, GE Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004 1412, made application by renewal to the Drug Enforcement
Administration (DEA) as a bulk manufacturer of Cocaine (9041), a basic class of controlled

Published: 2008-12-05 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28845] 23. Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 8, 2008, ISP Freetown Fine Chemicals, 238 South Main Street, Assonet, Massachusetts 02702, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of

Published: 2008-12-05 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28651] 24. Import and Production Quotas for Certain List I Chemicals

On March 9, 2006, the President signed the Combat Methamphetamine Epidemic Act of 2005, which mandates that DEA establish total annual requirements, and individual import, manufacturing, and procurement quotas for ephedrine, pseudoephedrine, and
phenylpropanolamine. DEA issued an Interim Final Rule establishing procedures for applying for

Published: 2008-12-03 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc E8-28432] 25. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated July 29, 2008, and published in the Federal Register on August 6, 2008 (73 FR 45784), Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Morphine (9300), a basic class of controlled substance

Published: 2008-12-01 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

Years: 20002001200220032004200520062007200820092010201120122013

Pages: 12345>»